BOQI International Medical Inc [BIMI] Rallies After 1026% Revenue Growth

Related Topics

Facebook
Twitter
LinkedIn
WhatsApp

BOQI International Medical Inc [NASDAQ:BIMI] is one of the top performers this afternoon, at a time when key indices have turned negative. The stock is currently up by over 50% and gaining. It’s upside momentum follows the release of stronger than expected Q2 results, including a huge increase in revenues compared to a similar period last year.

Breaking down the results, the company announced that total revenues rose by over 1026% compared to Q2 of 2019. The company also announced that its gross profit margins rose by 22.77% a significant increase when compared to Q2 of 2019 when it recorded a gross profit margin of 4.35%. The company also reported that its net income in Q2 of 2020 rose by 629% when compared to Q2 of 2019.

The company attributed its strong revenues growth to Guanzan Group’s sales of generic medications and medical devices. Guanzan Group is the latest asset purchase by BOQI International and one that has proven to be pivotal to the company’s revenue growth in Q2.

The revenue growth was also attributed to the sale of products made by t NF Group. It also attributed its revenue growth to the provision of technical services and partnerships in product processing services. The company’s gross profit margins for the quarter wholesale business mainly in the wholesale medical devices and wholesale medical segments which both grew by over 20% in the quarter.

The company’s net profits also recorded massive growth compared to a similar quarter in 2019. In specifics, the company reported a net profit of $4,673,854 when compared to a net loss of $883,245 in a similar period in 2019.

The company attributed the increase in net profits to money made from the sale of the NF Group. The company’s liquidity position also improved from $36,674 to $109,402.

Commenting on the results, CEO Tiewei Song said that they were happy with the Q2 results. He added that they had bought Guanzan Group allowing them to better align with the present business environment and long term growth.  He added that with more healthcare facilities opening up, the company expected demand for its products to rise, thereby adding value to the company’s shareholders.

About BOQI International Medical Inc

BOQI International Medical Inc is a distributor of pharmaceuticals and other healthcare products. The company runs through a network of 16 stores and mainly distributes its products in China. It is headquartered in Dalian, China.

Leave a Comment

Your email address will not be published.

Latest Posts